Toshiji Igarashi

Predictability of clinical adverse reactions of drugs by general pharmacology studies.

Toshiji Igarashi, Sadao NAKANE, Toshikazu Kitagawa · The Journal of Toxicological Sciences · 1995 · 75 citations · Full text

Drug Safety, Drug Hypersensitivity, Pharmacology +8

Chronic hypertension induced by streptozotocin in rats

Hidetoshi Kawashima, Toshiji Igarashi, Yoshikage Nakajima et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1978 · 62 citations

Hypertension, Blood Pressure, Cardiovascular Disease +7

Synthesis and Antiarrhythmic Activity of 2,2-Dialkyl-1'-(N-substituted aminoalkyl)-spiro-(chroman-4,4'-imidazolidine)-2',5'-diones.

Masayuki Matsukura, Yoshiharu Daiku, Kouichirou UEDA et al. · Chemical and Pharmaceutical Bulletin · 1992 · 47 citations · Full text

Pharmaceutical Chemistry, Novel Series, Biochemistry +8

.ALPHA.-Adrenoceptor blocking properties of a new antihypertensive agent,2-(4-(n-butyryl)-homopiperazine-1-yl)-4-amino-6,7-dimethoxyquinazoline (E-643).

Tadao Shoji, Yoshiharu Daiku, Toshiji Igarashi · The Japanese Journal of Pharmacology · 1980 · 35 citations · Full text

Modulation of diethylnitrosarnine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator

Satoru Hosokawa, Masae Tatematsu, Toyohiko Aoki et al. · Carcinogenesis · 1989 · 31 citations

Male F344 Rats, Mammalian Physiology, Pathology +18